ALTEOGEN (Korea) Today
| 196170 Stock | KRW 439,500 47,500 12.12% |
PerformanceSolid
| Odds Of DistressBelow Average
|
ALTEOGEN is trading at 439500.00 as of the 18th of March 2025, a 12.12 percent increase since the beginning of the trading day. The stock's open price was 392000.0. ALTEOGEN has about a 29 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
Moving together with ALTEOGEN Stock
Moving against ALTEOGEN Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ALTEOGEN Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ALTEOGEN's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ALTEOGEN or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology (View all Sectors) |
ALTEOGEN (196170) is traded on KOSDAQ in Korea and employs 103 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 549.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ALTEOGEN's market, we take the total number of its shares issued and multiply it by ALTEOGEN's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ALTEOGEN has 13.58 M outstanding shares.
ALTEOGEN has accumulated about 10.54 B in cash with (9.42 B) of positive cash flow from operations.
Check ALTEOGEN Probability Of Bankruptcy
Ownership AllocationThe market capitalization of ALTEOGEN is W549.88 Billion. ALTEOGEN retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check ALTEOGEN Ownership Details
ALTEOGEN Risk Profiles
Although ALTEOGEN's alpha and beta are two of the key measurements used to evaluate ALTEOGEN's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.83 | |||
| Semi Deviation | 2.82 | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.41 |
ALTEOGEN Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ALTEOGEN without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
ALTEOGEN Corporate Management
Elected by the shareholders, the ALTEOGEN's board of directors comprises two types of representatives: ALTEOGEN inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALTEOGEN. The board's role is to monitor ALTEOGEN's management team and ensure that shareholders' interests are well served. ALTEOGEN's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALTEOGEN's outside directors are responsible for providing unbiased perspectives on the board's policies.
| SoonJae Park | Chief Officer | Profile | |
| Hang Kim | CFO VP | Profile | |
| SangMee Lee | VP Planning | Profile | |
| Vivek MBA | Chief Officer | Profile | |
| Sang Kang | VP Group | Profile | |
| Kyuwan Kim | VP Devel | Profile | |
| TaeYon JD | Sr Officer | Profile |
Other Information on Investing in ALTEOGEN Stock
ALTEOGEN financial ratios help investors to determine whether ALTEOGEN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALTEOGEN with respect to the benefits of owning ALTEOGEN security.